These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 772247)
1. [Treatment of scarlet fever of children with new oral cephalosporin granules (S-640 P or cefatrizine granules) (author's transl)]. Sato H; Nakazawa S; Chikaoka H; Yamaguchi T Jpn J Antibiot; 1976 Feb; 29(2):184-88. PubMed ID: 772247 [No Abstract] [Full Text] [Related]
2. [Bacteriological studies on cefatrizine (S-640 P) (author's transl)]. Matsuzaki M; Tado N; Hirata Y; Kato M; Nakumura K Jpn J Antibiot; 1976 Jan; 29(1):61-8. PubMed ID: 4635 [No Abstract] [Full Text] [Related]
3. [Clinical evaluation of a new oral cephalosporin preparation, cephradine dry syrup, in pediatrics (author's transl)]. Fujii R; Yoshioka H; Nakamura T; Nakazawa S; Hori M Jpn J Antibiot; 1975 Apr; 28(2):125-31. PubMed ID: 239262 [No Abstract] [Full Text] [Related]
4. [Recurrent scarlet fever due to recent reinfection caused by strains unrelated to Streptococcus pyogenes]. Sanz JC; Bascones Mde L; Martín F; Sáez-Nieto JA Enferm Infecc Microbiol Clin; 2005; 23(6):388-9. PubMed ID: 15970177 [No Abstract] [Full Text] [Related]
5. [Clinical studies of cefditoren pivoxil in pediatric field]. Nishimura T; Tabuki K; Aoki S; Takagi M Jpn J Antibiot; 1993 Jul; 46(7):629-36. PubMed ID: 8371497 [TBL] [Abstract][Full Text] [Related]
6. [A clinical evaluation of cefdinir in pediatric infections]. Katsushima N; Sakamoto M Jpn J Antibiot; 1990 Aug; 43(8):1436-41. PubMed ID: 2283713 [TBL] [Abstract][Full Text] [Related]
7. [Clinical study of S-6437 in pediatrics (author's transl)]. Minamitani M; Hachimori K; Nakazawa H Jpn J Antibiot; 1977 Sep; 30(9):677-83. PubMed ID: 916188 [TBL] [Abstract][Full Text] [Related]
8. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)]. Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189 [No Abstract] [Full Text] [Related]
9. [Evaluation of 10 day administration method for therapy of scarlet fever]. Tomizawa I; Takizawa Y; Konishi K; Shimizu N; Tsuji M; Imagawa Y; Murata M; Tatsubara Y; Seo T; Sagara H Kansenshogaku Zasshi; 1983 Dec; 57(12):1108-14. PubMed ID: 6425433 [No Abstract] [Full Text] [Related]
10. [Scarlet fever and other infections from Streptococcus pyogenes]. Med Monatsschr Pharm; 2001 Mar; 24(3):83-6. PubMed ID: 11291694 [No Abstract] [Full Text] [Related]
11. [Therapeutic experience with cefadroxil syrup in acute infections, especially scarlet fever, in pediatric field (author's transl)]. Minamitani M; Hachimori K; Nakazawa H; Tomori N Jpn J Antibiot; 1981 Feb; 34(2):161-70. PubMed ID: 7253196 [TBL] [Abstract][Full Text] [Related]
12. Cefatrizine (SK&F 60771), a new oral cephalosporin: serum levels and urinary recovery in humans after oral or intramuscular administration--comparative study with cephalexin and cefazolin. Actor P; Pitkin DH; Lucyszyn G; Weisbach JA; Bran JL Antimicrob Agents Chemother; 1976 May; 9(5):800-3. PubMed ID: 949177 [TBL] [Abstract][Full Text] [Related]
13. [Application of clindamycin-2-palmitate to scarlet fever in children (author's transl)]. Ito T; Kawana T; Mizuhara H Jpn J Antibiot; 1973 Aug; 26(4):361-4. PubMed ID: 4542672 [No Abstract] [Full Text] [Related]
14. Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China. Chen M; Yao W; Wang X; Li Y; Chen M; Wang G; Zhang X; Pan H; Hu J; Zeng M Pediatr Infect Dis J; 2012 Sep; 31(9):e158-62. PubMed ID: 22531238 [TBL] [Abstract][Full Text] [Related]